Skip to: Content
Skip to: Site Navigation
Skip to: Search

December 2, 2008 11:22:47 AM CST



Study: Many Can Safely Skip Chemo for Breast Cancer

Posted Dec 14, 07 4:02 AM CST in Science & Health 

(Newser) – Thousands of breast cancer patients could be spared the misery and expense of chemotherapy, or at least get a milder regimen than what's usually prescribed, according to a new study. A new genetic test that predicts women's risk of recurrence shows that up to 40% of patients with early stage breast cancer could safely skip chemotherapy.

The findings should affect doctors' recommendations for chemotherapy, according to researchers who presented the study at the San Antonio Breast Cancer Symposium. But some say physicians are extremely reluctant to risk giving up any treatment that might help some. A separate study suggests that the drug Taxotere is at least as effective as the commonly prescribed Adriamycin, but has fewer serious side effects.

Source Associated Press

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
  (Associated Press)
Harry Keller receives a chemotherapy treatment at the offices of Los Gatos oncologist Dr. Jim Cohen.   (KRT Photos)
Nurse Ellen Plotsky prepares a chemotherapy treatment for Boggy Creek camper Heather Russell, 13, inside the hospital at the camp in Eustis, Florida.   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 1)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Science & Health Stories


What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »